Renal response to frusemide in preterm infants with respiratory distress syndrome during the first three postnatal days

T. F. Yeh, D. Raval, E. John, R. Spildes

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

he renal effects of frusemide treatment in infants with respiratory distress syndrome shortly after birth and during the first three postnatal days were evaluated. Eighty five infants were randomly assigned to two groups. Forty two received three doses of intravenous frusemide (1 mg/kg) starting at age, mean (SD) 7-5 (4-1) hours and given at approximately 24 hour intervals. Forty three control infants were treated similarly but were not given frusemide. The groups were comparable in birthweight, gestational age, and Apgar score and in pulmonary status, blood gases, serum electrolytes, and postnatal age. Infants who received frusemide had significantly higher fractional excretion of sodium and chloride at 12 to 24, 24 to 48, and 48 to 72 hours, and higher calcium excretion at 24 to 48 and 48 to 72 hours after entry into the study than control infants. The study group had a significantly higher urine output and greater weight loss than the control group at 48 to 72 hours after entry into the study. There was no significant difference between groups in serum sodium, potassium, and calcium and in fractional excretion of potassium and the glomerular filtration rate. Infants with an Apgar score of more than 3 had higher urine output and had a better diuretic response to frusemide than those with a lower score. The results suggest that perinatal hypoxia may play an important role in renal function and in diuretic response to frusemide shortly after birth and early in the postnatal life of infants with respiratory distress syndrome.

Original languageEnglish
Pages (from-to)621-626
Number of pages6
JournalArchives of Disease in Childhood
Volume60
Issue number7
DOIs
Publication statusPublished - Jan 1 1985
Externally publishedYes

Fingerprint

Newborn Respiratory Distress Syndrome
Furosemide
Premature Infants
Kidney
Apgar Score
Diuretics
Potassium
Urine
Calcium
Birth Order
Serum
Glomerular Filtration Rate
Sodium Chloride
Electrolytes
Gestational Age
Weight Loss
Gases
Sodium
Parturition
Lung

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Renal response to frusemide in preterm infants with respiratory distress syndrome during the first three postnatal days. / Yeh, T. F.; Raval, D.; John, E.; Spildes, R.

In: Archives of Disease in Childhood, Vol. 60, No. 7, 01.01.1985, p. 621-626.

Research output: Contribution to journalArticle

@article{3a85682cfdfd403fb3da84561f8ccb13,
title = "Renal response to frusemide in preterm infants with respiratory distress syndrome during the first three postnatal days",
abstract = "he renal effects of frusemide treatment in infants with respiratory distress syndrome shortly after birth and during the first three postnatal days were evaluated. Eighty five infants were randomly assigned to two groups. Forty two received three doses of intravenous frusemide (1 mg/kg) starting at age, mean (SD) 7-5 (4-1) hours and given at approximately 24 hour intervals. Forty three control infants were treated similarly but were not given frusemide. The groups were comparable in birthweight, gestational age, and Apgar score and in pulmonary status, blood gases, serum electrolytes, and postnatal age. Infants who received frusemide had significantly higher fractional excretion of sodium and chloride at 12 to 24, 24 to 48, and 48 to 72 hours, and higher calcium excretion at 24 to 48 and 48 to 72 hours after entry into the study than control infants. The study group had a significantly higher urine output and greater weight loss than the control group at 48 to 72 hours after entry into the study. There was no significant difference between groups in serum sodium, potassium, and calcium and in fractional excretion of potassium and the glomerular filtration rate. Infants with an Apgar score of more than 3 had higher urine output and had a better diuretic response to frusemide than those with a lower score. The results suggest that perinatal hypoxia may play an important role in renal function and in diuretic response to frusemide shortly after birth and early in the postnatal life of infants with respiratory distress syndrome.",
author = "Yeh, {T. F.} and D. Raval and E. John and R. Spildes",
year = "1985",
month = "1",
day = "1",
doi = "10.1136/adc.60.7.621",
language = "English",
volume = "60",
pages = "621--626",
journal = "Archives of Disease in Childhood",
issn = "0003-9888",
publisher = "BMJ Publishing Group",
number = "7",

}

TY - JOUR

T1 - Renal response to frusemide in preterm infants with respiratory distress syndrome during the first three postnatal days

AU - Yeh, T. F.

AU - Raval, D.

AU - John, E.

AU - Spildes, R.

PY - 1985/1/1

Y1 - 1985/1/1

N2 - he renal effects of frusemide treatment in infants with respiratory distress syndrome shortly after birth and during the first three postnatal days were evaluated. Eighty five infants were randomly assigned to two groups. Forty two received three doses of intravenous frusemide (1 mg/kg) starting at age, mean (SD) 7-5 (4-1) hours and given at approximately 24 hour intervals. Forty three control infants were treated similarly but were not given frusemide. The groups were comparable in birthweight, gestational age, and Apgar score and in pulmonary status, blood gases, serum electrolytes, and postnatal age. Infants who received frusemide had significantly higher fractional excretion of sodium and chloride at 12 to 24, 24 to 48, and 48 to 72 hours, and higher calcium excretion at 24 to 48 and 48 to 72 hours after entry into the study than control infants. The study group had a significantly higher urine output and greater weight loss than the control group at 48 to 72 hours after entry into the study. There was no significant difference between groups in serum sodium, potassium, and calcium and in fractional excretion of potassium and the glomerular filtration rate. Infants with an Apgar score of more than 3 had higher urine output and had a better diuretic response to frusemide than those with a lower score. The results suggest that perinatal hypoxia may play an important role in renal function and in diuretic response to frusemide shortly after birth and early in the postnatal life of infants with respiratory distress syndrome.

AB - he renal effects of frusemide treatment in infants with respiratory distress syndrome shortly after birth and during the first three postnatal days were evaluated. Eighty five infants were randomly assigned to two groups. Forty two received three doses of intravenous frusemide (1 mg/kg) starting at age, mean (SD) 7-5 (4-1) hours and given at approximately 24 hour intervals. Forty three control infants were treated similarly but were not given frusemide. The groups were comparable in birthweight, gestational age, and Apgar score and in pulmonary status, blood gases, serum electrolytes, and postnatal age. Infants who received frusemide had significantly higher fractional excretion of sodium and chloride at 12 to 24, 24 to 48, and 48 to 72 hours, and higher calcium excretion at 24 to 48 and 48 to 72 hours after entry into the study than control infants. The study group had a significantly higher urine output and greater weight loss than the control group at 48 to 72 hours after entry into the study. There was no significant difference between groups in serum sodium, potassium, and calcium and in fractional excretion of potassium and the glomerular filtration rate. Infants with an Apgar score of more than 3 had higher urine output and had a better diuretic response to frusemide than those with a lower score. The results suggest that perinatal hypoxia may play an important role in renal function and in diuretic response to frusemide shortly after birth and early in the postnatal life of infants with respiratory distress syndrome.

UR - http://www.scopus.com/inward/record.url?scp=0021831785&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021831785&partnerID=8YFLogxK

U2 - 10.1136/adc.60.7.621

DO - 10.1136/adc.60.7.621

M3 - Article

VL - 60

SP - 621

EP - 626

JO - Archives of Disease in Childhood

JF - Archives of Disease in Childhood

SN - 0003-9888

IS - 7

ER -